We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Suppression of CD56bright NK cells in breast cancer patients is associated with the PD-1 and TGF-βRII expression

    Background

    Natural killer (NK) cells, as professional cytotoxic cells, play a key role against cancer in the early and metastatic stages. Their...

    Elaheh Arianfar, Seyed Reza Khandoozi, ... Ali Memarian in Clinical and Translational Oncology
    Article 21 November 2022
  2. PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients

    A variety of variables, such as microsatellite instability or inflammatory mediators, are critical players in the development and progression of...

    Mohammad A. Al-Mterin, Khaled Murshed, Eyad Elkord in Cancer Immunology, Immunotherapy
    Article Open access 27 November 2022
  3. NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice

    Background

    Cancer is the leading cause of death among older adults. Although the integration of immunotherapy has revolutionized the therapeutic...

    Junlei Hou, Shuanglong **e, ... **nxin Wang in Experimental Hematology & Oncology
    Article Open access 09 May 2024
  4. High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer

    High expression of immune checkpoint receptors (ICRs) in the tumor microenvironment regulates the anti-tumor response. In this study, the...

    Baran Mollavelioglu, Esin Cetin Aktas, ... Vahit Ozmen in World Journal of Surgical Oncology
    Article Open access 21 October 2022
  5. Increased TIM-3+PD-1+ NK cells are associated with the disease activity and severity of systemic lupus erythematosus

    It is well established that natural killer (NK) cells are dysregulated in systemic lupus erythematosus (SLE) patients. However, the functions of NK...

    Qing Luo, Yunyuan Kong, ... Junming Li in Clinical and Experimental Medicine
    Article Open access 08 June 2021
  6. Programmable synthetic receptors: the next-generation of cell and gene therapies

    Cell and gene therapies hold tremendous promise for treating a range of difficult-to-treat diseases. However, concerns over the safety and efficacy...

    Fei Teng, Tongtong Cui, ... Wei Li in Signal Transduction and Targeted Therapy
    Article Open access 03 January 2024
  7. Hypoxia-inducible factor-1 alpha expression is induced by IL-2 via the PI3K/mTOR pathway in hypoxic NK cells and supports effector functions in NKL cells and ex vivo expanded NK cells

    Natural killer (NK) cells are cytotoxic innate lymphocytes that are specialized to kill tumor cells. NK cells are responsive to the primary cytokine...

    Emily Cluff, Carina C. Magdaleno, ... Narendiran Rajasekaran in Cancer Immunology, Immunotherapy
    Article Open access 09 January 2022
  8. The role of histamine and its receptors in breast cancer: from pathology to therapeutic targets

    Breast cancer is the most common malignancy in women, and despite the development of new treatment methods and the decreasing mortality rate in...

    Hossein Azimi, Afifeh Jafari, ... Homa Davoodi in Medical Oncology
    Article 01 July 2024
  9. CD56bright NK cell expansion correlated with EBV reactivation control post allogeneic hematopoietic stem cell transplantation

    Natural killer (NK) cells are equipped with anti-Epstein-Barr virus (EBV) function, however, whether EBV infection will affect NK cells...

    **e Juan, Zeying Fan, ... **angyu Zhao in Annals of Hematology
    Article 11 June 2024
  10. Therapeutic applications of toll-like receptors (TLRs) agonists in AML

    Acute myeloid leukemia (AML) is an aggressive type of blood cancer affecting bone marrow (BM). In AML, hematopoietic precursors are arrested in the...

    Ye Peng, Yanzhong Wang, ... Yirui Chen in Clinical and Translational Oncology
    Article 13 August 2022
  11. Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review

    Hormones and its regulation plays vital role in causing breast, prostate, ovarian and endometrial cancers collectively known as hormone-sensitive...

    Suvitha Anbarasu, Anand Anbarasu in Medical Oncology
    Article 10 May 2023
  12. The role of toll-like receptors (TLRs) and their therapeutic applications in glomerulonephritis

    One of the most important features of innate immunity is the presence of a special group of pattern recognition receptors (PRRs) called toll-like...

    Feiyan Liu, Huimin Chen, ... Ying Zhou in International Urology and Nephrology
    Article 15 April 2023
  13. CC chemokines and receptors in osteoarthritis: new insights and potential targets

    Osteoarthritis (OA) is a prevalent degenerative disease accompanied by the activation of innate and adaptive immune systems-associated inflammatory...

    Yuchen Zhang, Di Liu, ... Yusheng Li in Arthritis Research & Therapy
    Article Open access 03 July 2023
  14. Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy

    Natural killer (NK) cells mediate potent anti-tumor responses, which makes them attractive targets for immunotherapy. The anti-tumor response of...

    Nicky A. Beelen, Femke A. I. Ehlers, ... Lotte Wieten in Cancer Immunology, Immunotherapy
    Article Open access 19 October 2022
  15. Reactivation of natural killer cells with monoclonal antibodies in the microenvironment of malignant neoplasms

    Natural killer cells are critical players in the antitumor immune response due to their ability to destroy target cells through cytotoxic activity...

    Luiz Ricardo Soldi, Victor Luigi Costa Silva, ... Marcelo José Barbosa Silva in Journal of Cancer Research and Clinical Oncology
    Article 12 January 2023
  16. Refurbishment of NK cell effector functions through their receptors by depleting the activity of nTreg cells in Dalton’s Lymphoma-induced tumor microenvironment: an in vitro and in vivo study

    Natural killer (NK) cells play a crucial role in the anti-tumor transaction through cytolytic activity with the help of proportionate expression of...

    Munendra Singh Tomar, Rishi Kant Singh, ... Arbind Acharya in Cancer Immunology, Immunotherapy
    Article 03 December 2022
  17. Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension

    Background

    Pulmonary arterial hypertension (PAH), Group 1 pulmonary hypertension (PH), is a type of pulmonary vascular disease characterized by...

    Cheng Zeng, **g Liu, ... Yuhu He in Respiratory Research
    Article Open access 01 November 2023
  18. Therapeutic applications of engineered chimeric antigen receptors-T cell for cancer therapy

    Background

    Findings of new targeted treatments with adequate safety evaluations are essential for better cancer cures and mortality rates....

    Article Open access 11 April 2022
  19. Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome

    Insofar as they play an important role in the pathogenesis of colorectal cancer (CRC), this study analyzes the serum profile of cytokines,...

    M. Stayoussef, X. Weili, ... B. Yacoubi-Loueslati in Cancer Immunology, Immunotherapy
    Article Open access 02 July 2024
Did you find what you were looking for? Share feedback.